Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades

Neuroscience

Volumn 156, Issue 4, 2008, Pages 898-910

  Matos, M ^a   Augusto, E ^a   Oliveira, C R ^a,b   Agostinho, P ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

amyloid beta; astrocytes; glutamate transport; MAP kinases; oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; ASPARTIC ACID; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN C JUN; TRITIUM; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CONTROLLED STUDY; ISOTOPE LABELING; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANTIOXIDANTS; ASPARTIC ACID; ASTROCYTES; CELLS, CULTURED; CEREBRAL CORTEX; CHROMANS; ENZYME INHIBITORS; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; MITOGEN-ACTIVATED PROTEIN KINASES; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRITIUM;

EID: 53949085542     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.08.022     Document Type: Article

References (62)

1. Abe K., and Misawa M. The extracellular signal-regulated kinase cascade suppresses amyloid beta protein-induced promotion of glutamate clearance in cultured rat cortical astrocytes. Brain Res 979 (2003) 179-187
2. Abe K., and Misawa M. Amyloid beta protein enhances the clearance of extracellular L-glutamate by cultured rat cortical astrocytes. Neurosci Res 45 (2003) 25-31
3. Abe K., Hisatomi R., and Misawa M. Amyloid beta peptide specifically promotes phosphorylation and nuclear translocation of the extracellular signal-regulated kinase in cultured rat cortical astrocytes. J Pharmacol Sci 93 (2003) 272-278
4. Agostinho P., Duarte C.B., and Oliveira C.R. Impairment of excitatory amino acid transporter activity by oxidative stress conditions in retinal cells: effect of antioxidants. FASEB J 11 (1997) 154-163
5. Agostinho P., and Oliveira C.R. Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur J Neurosci 17 (2003) 1189-1196
6. Agostinho P., and Oliveira C.R. Neuroinflammation and mitochondrial dysfunction in Alzheimer's and prion's diseases. In: Malva J.O., Rego A.C., Cunha R.A., and Oliveira C.R. (Eds). Interaction between neurons and glia in aging and disease (2007), Springer Publishers, New York 309-332
7. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., Cooper N.R., Eikelenboom P., Emmerling M., Fiebich B.L., Finch C.E., Frautschy S., Griffin W.S., Hampel H., Hull M., Landreth G., Lue L., Mrak R., Mackenzie I.R., McGeer P.L., O'Banion M.K., Pachter J., Pasinetti G., Plata-Salaman C., Rogers J., Rydel R., Shen Y., Streit W.J., Strohmeyer R., Tooyoma I., Van Muiswinkel F.L., Veerhuis R., Walker D., Webster S., Wegrzyniak B., Wenk G., and Wyss-Coray T. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
8. Anderson C.M., and Swanson R.A. Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32 (2000) 1-14
9. Berry C.B., Hayes D., Murphy A., Wiessner M., Rauen T., and McBean G.J. Differential modulation of the glutamate transporters GLT-1, GLAST and EAAC1 by docosahexaenoic acid. Brain Res 1037 (2005) 123-133
10. Blennow K., de Leon M.J., and Zetterberg H. Alzheimer's disease. Lancet 368 (2006) 387-403
11. Brera B., Serrano A., and Ceballos M.L. Beta-amyloid peptide are cytotoxic to astrocytes in culture: a role for oxidative stress. Neurobiol Dis 7 (2000) 395-405
12. Butterfield D.A., Howard B.J., Yatin S., Allen K.L., and Carney J.M. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci U S A 94 (1997) 674-678
13. Celsi F., Svedberg M., Unger C., Cotman C.W., Carrì M.T., Ottersen O.P., Nordberg A., and Torp R. Beta-amyloid causes downregulation of calcineurin in neurons through induction of oxidative stress. Neurobiol Dis 26 (2007) 342-352
14. Chauan V., and Chauan A. Oxidative stress in Alzheimer disease. Pathophysiology 13 (2006) 195-208
15. Dabir D.V., Robinson M.B., Swanson E., Zhang B., Trojanowski J.Q., Lee V.M., and Forman M.S. Impaired glutamate transport in a mouse model of tau pathology in astrocytes. J Neurosci 26 (2006) 644-654
16. Daniels W.M., Hendricks J., Salie R., and Taljaard J.J. The role of the MAP-kinase superfamily in beta-amyloid toxicity. Metab Brain Dis 16 (2001) 175-185
17. Fernández-Tomé P., Brera B., Arévalo M., and Ceballos M.L. β-Amyloid 25-35 inhibits glutamate uptake in cultured neurons and astrocytes: modulation of uptake as a survival mechanism. Neurobiol Dis 15 (2004) 580-589
18. Ferrarese C., Begni B., Canevari C., Zoia C., Piolti R., Frigo M., Appollonio I., and Frattola L. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann Neurol 47 (2000) 641-643
19. Ferreiro E., Resende R., Costa R., Oliveira C.R., and Pereira C.M. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity. Neurobiol Dis 23 (2006) 669-678
20. Ferrer I., Blanco R., Carmona M., and Puig B. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. J Neural Transm 108 (2001) 1397-1415
21. Figiel M., Maucher T., Rozyczka J., Bayatti N., and Engele J. Regulation of glial glutamate transporter expression by growth factors. Exp Neurol 183 (2004) 124-135
22. Francis P.T. Glutamatergic systems in Alzheimer's disease. Int J Geriatr Psychiatry 18 (2003) S15-S21
23. Garção P., Oliveira C.R., and Agostinho P. Comparative study of microglia activation induced by amyloid-beta and prion peptides: role in neurodegeneration. J Neurosci Res 84 (2006) 182-193
24. Gegelashvili G., and Schousboe A. High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol 52 (1997) 6-15
25. Gegelashvili G., Dehnes Y., Danbolt N.C., and Schousboe A. The high-affinity glutamate transporters GLT-1, GLAST, and EAAT4 are regulated via different signaling mechanisms. Neurochem Int 37 (2000) 163-170
26. Harris M.E., Carney J.M., Cole P.S., Hensley K., Howard B.J., Martin L., Bummer P., Wang Y., Pedigo Jr. N.W., and Butterfield D.A. Beta-amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer's disease. Neuroreport 6 (1995) 1875-1879
27. +-dependent glutamate uptake in rat hippocampal astrocyte cultures. J Neurochem 67 (1996) 277-286
28. Hynd M.R., Scott H.L., and Dodd P.R. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease. Neurochem Int 45 (2004) 583-595
29. Jayakumar A.R., Panickar K.S., Murthy C.H.R.K., and Norenberg M.D. Oxidative stress and mitogen-activated protein kinase phosphorylation mediate ammonia-induced cell swelling and glutamate uptake inhibition in cultured astrocytes. J Neurosci 26 (2006) 4774-4784
30. Kanai Y., Smith C.P., and Hediger M.A. A new family of neurotransmitter transporters: the high-affinity glutamate transporters. FASEB J 8 (1994) 1450-1459
31. Klein W.L., Stine Jr. W.B., and Teplow D.B. Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging 25 (2004) 569-580
32. Koistinaho M., Lin S., Wu X., Esterman M., Koger D., Hanson J., Higgs R., Liu F., Malkani S., Bales K.R., and Paul S.M. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10 (2004) 719-726
33. LaFerla F.M. Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat Rev Neurosci 11 (2002) 862-872
34. +-dependent glutamate uptake. Life Sci 65 (1999) 1977-1981
35. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesbery W.R., and Butterfield D.A. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78 (2001) 413-416
36. Li S., Mallory M., Alford M., Tanaka S., and Masliah E. Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. J Neuropathol Exp Neurol 56 (1997) 901-911
37. Liang Z., Valla J., Sefidvash-Hockley S., Rogers J., and Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J Neurochem 80 (2002) 807-814
38. Mandell J.W., and VandenBerg S.R. ERK/MAP kinase is chronically activated in human reactive astrocytes. NeuroReport 10 (1999) 3567-3572
39. Maragakis N.J., and Rothstein J.D. Mechanisms of disease: astrocytes in neurodegenerative disease. Nat Clin Pract Neurol 2 (2006) 679-689
40. Masliah E., Alford M., DeTeresa R., Mallory M., and Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann Neurol 40 (1996) 759-766
41. Masliah E., Alford M., Mallory M., Rockenstein E., Moechars D., and Leuven F.V. Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp Neurol 163 (2000) 381-387
42. Mattson M.P., and Chan S.L. Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34 (2003) 385-397
43. McCubrey J.A., LaHair M.M., and Franklin R.A. Reactive oxygen species-induced activation of the MAP kinase signaling pathways. Antioxid Redox Signal 8 (2006) 1775-1789
44. Parpura-Gill A., Beitz D., and Uemura E. The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes. Brain Res 754 (1997) 65-71
45. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
46. 2+ homeostasis. Brain Res 1143 (2007) 11-21
47. Resende R, Ferreiro E, Pereira C, Oliveira CR (2008) Neurotoxic effect of oligomeric and fibrillar species of Abeta1-42 peptide. Involvement of ER calcium release in oligomers-induced cell death. Neuroscience, in press.
48. Rodriguez-Kern A., Gegelashvili M., Schousboe A., Zhang J., Sung L., and Gegelashvili G. Beta-amyloid and brain-derived neurotrophic factor, BDNF, up-regulate the expression of glutamate transporter GLT-1/EAAT2 via different signaling pathways utilizing transcription factor NF-kappaB. Neurochem Int 43 (2003) 363-370
49. Rohrdanz E., Schmuck G., Ohler S., Tran-Thi Q.H., and Kahl R. Changes in antioxidant enzyme expression in response to hydrogen peroxide in rat astroglial cells. Arch Toxicol 75 (2001) 150-158
50. Rothstein J.D., Van Kammen M., Levey A.I., Martin L.J., and Kuncl R.W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 38 (1995) 73-84
51. Rothstein J.D., Patel S., Regan M.R., Haenggeli C., Huang Y.H., Bergles D.E., Jin L., Hoberg M.D., Vidensky S., Chung D.S., Toan S.V., Bruijn L.I., Su Z., Gupta P., and Fisher P.B. B-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433 (2005) 73-77
52. Saura J. Microglial cells in astroglial cultures: a cautionary note. J Neuroinflammation 15 (2007) 4-26
53. Scott H.L., Tannenberg A.E., and Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J Neurochem 64 (1995) 2193-2202
54. Scott H.L., Pow D.V., and Tannenberg A.E. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J Neurosci 22 (2002) 1-5
55. Streit W.J. Microglia and Alzheimer's disease pathogenesis. Neurosci Res 77 (2004) 1-8
56. Sultana R., and Butterfield D.A. Alterations of some membrane transport proteins in Alzheimer's disease: role of amyloid β-peptide. Mol Biosyst 4 (2008) 36-41
57. Thorlin T., Roginski R.S., Choudhury K., Nilsson M., Rönnbäck L., Hansson E., and Eriksson P.S. Regulation of the glial glutamate transporter GLT-1 by glutamate and delta-opioid receptor stimulation. FEBS Lett 425 (1998) 453-459
58. Webster B., Hansen L., Adame A., Crews L., Torrance M., Thal L., and Masliah E. Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease. J Neuropathol Exp Neurol 65 (2006) 142-151
59. White J.A., Manelli A.M., Holmberg K.H., Van Eldik L.J., and Ladu M.J. Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis 18 (2005) 459-465
60. Wyss-Coray T., Loike J.D., Brionne T.C., Lu E., Anankov R., Yan F., Silverstein S.C., and Husemann J. Adult mouse astrocytes degrade amyloid-beta in vitro and in situ. Nat Med 9 (2003) 453-457
61. Zhu X., Lee H.G., Raina A.K., Perry G., and Smith M.A. The role of mitogen-activated protein kinase pathways in Alzheimer's disease. Neurosignals 11 (2002) 270-281
62. Zoia C.P., Tagliabue E., Isella V., Begni B., Fumagalli L., Brighina L., Appollonio I., Racchi M., and Ferrarese C. Fibroblast glutamate transport in aging and in AD: correlations with disease severity. Neurobiol Aging 26 (2005) 825-832